Summer Sale
50% off Premium Yearly
00days
00hrs
00mins
00secs
Opinions Gordon Reid
Immucor Inc.BLUDTOP PICKSep 10, 2008
Manufactures and develops agents for testing of human blood prior to blood transfusions. A lot of this was done manually but is now done through their technology. Growing very rapidly. Strong balance sheet. ROE’s of about 25%. Long-term growth rate of about 20%.
Gordon ReidOwned
$31.98
Stock price when the opinion was issued
biotechnologypharmaceutical
It's the ideal tool to help you make quicker, more informed decisions for managing and tracking your investments.
You might be interested:
PAST TOP PICK
(Top Pick Sep 10’08, Down 43%) They think the multiple will build back up. He is a buyer.
Gordon ReidOwned
biotechnologypharmaceutical
